Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Denmark
  4. Nasdaq Copenhagen
  5. H. Lundbeck A/S
  6. News
  7. Most relevant
    LUN   DK0010287234

H. LUNDBECK A/S

(LUN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about H. LUNDBECK A/S
07/22H LUNDBECK A/S : What do you mean brain health?
PU
07/01Denovo Biopharma LLC Announces In-Licenses Late-Stage Alzheimer's Disease Ass..
CI
06/15#1VOICESUMMIT : Partnering with the advocacy community to further brain health a..
PU
06/11H LUNDBECK A/S : Lundbeck CEO, Deborah Dunsire, warns that we could be on the br..
PU
05/31H LUNDBECK A/S : Interpretation Of The Term "export" In The Indian Patent Contex..
AQ
05/26H LUNDBECK A/S : Transactions with shares and linked securities in H. Lundbeck A..
AQ
05/24H LUNDBECK A/S : The Hunt for a New Weapon Against Schizophrenia
PU
05/20Verantos and Lundbeck Announce Partnership for Migraine Care Implementing Adv..
CI
05/11H LUNDBECK A/S : Lundbeck delivers a solid EBIT of DKK 882 million and Vyepti is..
AQ
05/11H. Lundbeck A/S Provides Revenue Guidance for the Full Year of Fiscal 2021
CI
05/11H. Lundbeck A/S Reports Earnings Results for the First Quarter Ended March 31..
CI
05/03H LUNDBECK A/S : Lundbeck - New study finds that vortioxetine helps patients wit..
AQ
05/03H LUNDBECK A/S : Lundbeck Drug Improves Symptoms in People With Major Depressive..
MT
05/03H LUNDBECK A/S : New study finds that vortioxetine helps patients with MDD and c..
AQ
05/02H. Lundbeck A/S Announces New Study Finds That Vortioxetine Helps Patients wi..
CI
04/22H LUNDBECK A/S : Vortioxetine significantly improves overall functioning in a gl..
AQ
04/22H. Lundbeck A/S Announces Positive Results from the Relieve (Real World Effec..
CI
04/13H LUNDBECK A/S : Lundbeck and Otsuka announce decision to continue phase III cli..
PU
04/13H LUNDBECK A/S : Lundbeck, Otsuka to Push Through With Recruitment in Late-Stage..
MT
04/13Otsuka and Lundbeck Announce Decision to Continue Phase IIII Clinical Trial E..
CI
04/13H LUNDBECK A/S : Lundbeck and Otsuka announce decision to continue phase III cli..
AQ
04/13H. Lundbeck A/S and Otsuka Pharmaceutical Co., Ltd. Announce Decision to Cont..
CI
03/24H. LUNDBECK A/S : Ex-dividend day for final dividend
FA
03/23H LUNDBECK A/S : Lundbeck held its Annual General Meeting on 23 March 2021 as a ..
AQ
03/23H. Lundbeck A/S Provides earnings Guidance for 2021
CI
03/19Scandion Oncology Appoints New COO
MT
03/17H LUNDBECK A/S : Lundbeck appoints Dr. Tarek Samad as Head of Research
AQ
03/17H. Lundbeck A/S Appoints Tarek Samad as Head of Research, Effective on May 1,..
CI
03/12H LUNDBECK A/S : Supplement to notice of Annual General Meeting
PU
03/12H LUNDBECK A/S : Lundbeck – New member proposed for election to Board of D..
PU
03/12H LUNDBECK A/S : Lundbeck - New member proposed for election to Board of Directo..
AQ
03/12H. Lundbeck A/S Announces Resignation of Henrik Andersen from Board
CI
03/04H LUNDBECK A/S : Transactions with shares and linked securities in H. Lundbeck A..
AQ
03/01H LUNDBECK A/S : Lundbeck A/S - Notice of Annual General Meeting
AQ
03/01195;rsted A/S Resolutions Of The Annual General Meeting 2021 Of Ørsted A/S
DJ
02/08H LUNDBECK A/S : Transactions with shares and linked securities in H. Lundbeck A..
PU
02/04H LUNDBECK A/S : Transactions with shares and linked securities in H. Lundbeck A..
AQ
02/04H LUNDBECK A/S : Sustainability Report
PU
02/04H. Lundbeck A/S Provides Earnings Guidance for the Fiscal Year 2021
CI
02/04H LUNDBECK A/S : Lundbeck Asks Partners for 20% Cut in Carbon Footprint by 2034,..
MT
02/04H LUNDBECK A/S : Lundbeck Cuts 2020 Dividend as Profit Plummets Amid Higher R&D ..
MT
02/04H LUNDBECK A/S : Lundbeck sets new 15-year climate target, towards achieving net..
PU
02/04H LUNDBECK A/S : Annual Report 2020 for H. Lundbeck A/S
AQ
02/04H. Lundbeck A/S Reports Earnings Results for the Full Year Ended December 31,..
CI
02/04H LUNDBECK A/S : In an unprecedented year, Lundbeck delivers sales growth of 4% ..
AQ
02/04H. Lundbeck A/S Proposes Dividend
CI
01/12H LUNDBECK A/S : Rigshospitalet and Lundbeck announce partnership to find new wa..
AQ
01/12Rigshospitalet and Lundbeck Announce Partnership to Find New Ways to Treat Br..
CI
01/06H. LUNDBECK A/S : - Adjusted Supplementary Information to the Annual Report 2019
AQ
01/05H LUNDBECK A/S : Adjusted Supplementary Information to the Annual Report 2019
AQ
2020H LUNDBECK A/S : The Danish Business Authority (“Erhvervsstyrelsen”)..
PU
2020H LUNDBECK A/S : Lundbeck announces European Medicines Agency acceptance of mark..
AQ
2020Lundbeck Announces European Medicines Agency Acceptance of Marketing Authoriz..
CI
2020H. LUNDBECK A/S(CPSE : LUN) dropped from OMX Copenhagen 20 Index
CI
2020H LUNDBECK A/S : Lundbeck is ranked as one of the world's leading companies for ..
PU
2020H LUNDBECK A/S : Lundbeck is ranked as one of the world's leading companies for ..
AQ
2020SENZAGEN : receives SEK 0.4 m order for GARD®skin and GARD®air tests from pharma..
AQ
2020H LUNDBECK A/S : The Danish Business Authority requires Lundbeck to conduct a ne..
AQ
2020H LUNDBECK A/S : The Danish Business Authority ("Erhvervsstyrelsen") requires Lu..
AQ
2020H. Lundbeck A/S Revises Earnings Guidance for the Fiscal Year 2020
CI
2020H LUNDBECK A/S : Solid performance across strategic brands with 19% growth in th..
AQ
2020H. Lundbeck A/S Revises Earnings Guidance for the Year 2020
CI
2020H. Lundbeck A/S Reports Earnings Results for the Third Quarter Ended Septembe..
CI
2020H LUNDBECK A/S : Lundbeck successfully places its first EUR 500 million Eurobond..
AQ
2020H LUNDBECK A/S : Lundbeck successfully places its first EUR 500 million Eurobond..
AQ
2020Lundbeck Successfully Places Its First EUR 500 Million Eurobond Issue
CI
2020H LUNDBECK A/S : Lundbeck presents positive data from the COMPLETE study with vo..
AQ
2020H LUNDBECK A/S : Lundbeck presents positive data from the COMPLETE study with vo..
AQ
2020H. Lundbeck A/S Presents Positive Data from the Complete Study with Vortioxet..
CI
2020H. LUNDBECK A/S : - Positive headline results from the Vyepti RELIEF study
AQ
2020H. Lundbeck A/S Announces Headline Results from the Parallel Group, Double-Bl..
CI
2020H LUNDBECK A/S : Strong momentum across all strategic brands with 25% growth in ..
AQ
2020H. Lundbeck A/S Provides Revenue Guidance for Financial Year 2020
CI
2020H. Lundbeck A/S Reports Earnings Results for the Second Quarter Ended June 30..
CI
2020H LUNDBECK A/S : Lundbeck discontinues phase II proof of concept study of Lu AF1..
AQ
1  2  3  4  5  6  7Next
Upcoming event on H. LUNDBECK A/S
08/18/21